The cost of health insurance rose steeply for a third year in a row in 2025, reaching just under $27,000 for a family plan, according to an annual survey

A recent employer survey reveals that health insurance premiums for families are set to rise in 2025, placing a heavier financial burden on both companies and their employees. This increase is significant as it highlights the ongoing challenges in the healthcare system, affecting the affordability of essential coverage for many families. As costs continue to climb, it raises concerns about access to necessary medical services and the overall financial well-being of workers.

Novo Nordisk, the maker of Ozempic, is undergoing significant leadership changes as it aims to recover lost market share in the competitive weight-loss drug sector. The company's controlling shareholder plans to replace seven directors, including the chairman, highlighting the urgency of the situation. This shake-up is crucial as the company faces increasing pressure from competitors and needs to realign its strategy to maintain its position in the market.

Sir Julian, the chief executive of the Care Quality Commission, has resigned following mounting pressure from families demanding accountability for poor maternity care at Leeds Teaching Hospitals NHS Trust. This resignation highlights ongoing concerns about the quality of healthcare services and the need for improvements in patient safety, particularly in maternity wards, which are crucial for families during such a vulnerable time.

The ongoing government shutdown is reigniting discussions about the future of health coverage under the Affordable Care Act, a topic that has divided major political parties for over a decade. As negotiations stall, the implications for millions of Americans relying on these health services remain uncertain, highlighting the urgent need for a resolution.

It's been ten years since the Aliso Canyon disaster, which marked the worst natural gas blowout in U.S. history. While some progress has been made in addressing the issues that arose from this event, many promises have yet to be fulfilled. This situation serves as a crucial reminder of the potential dangers associated with underground gas storage and the need for stricter regulations to prevent future incidents.

Roche has raised its full-year earnings outlook, reflecting strong performance and increased sales, excluding currency fluctuations. This is significant as it highlights the company's resilience and adaptability in a challenging market, especially amid ongoing discussions about drug pricing in the U.S. Investors and stakeholders will be keen to see how these factors influence Roche's future growth and strategy.

A recent push at the state level aims to challenge the long-standing monopoly of a drug that has dominated the market for 30 years. This initiative is crucial as it seeks to lower prices and improve access to essential medications for patients. With rising healthcare costs being a significant concern, this movement could pave the way for more affordable treatment options, ultimately benefiting many who rely on this medication.

A recent study has revealed that the side effects of antidepressants can vary significantly depending on the specific medication. With millions of Americans relying on these drugs for mental health support, understanding these differences is crucial for both patients and healthcare providers. This research highlights the importance of personalized treatment plans and informed discussions about medication options.